SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tamara Alpermann, Claudia Haferlach, Christiane Eder, Niroshan Nadarajah, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger, AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients, Leukemia Research, 2015, 39, 3, 265

    CrossRef

  2. 2
    Pierre Hirsch, Myriam Labopin, Frank Viguié, Christine Perot, Françoise Isnard, Anne-Claire Mamez, Chrystèle Bilhou-Nabera, Christophe Marzac, François Delhommeau, Simona Lapusan, Jean Pierre Marie, Mohamad Mohty, Ollivier Legrand, Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution, Leukemia Research, 2014, 38, 8, 907

    CrossRef

  3. 3
    Maximilian Christopeit, Nicolaus Kröger, Torsten Haferlach, Ulrike Bacher, Relapse assessment following allogeneic SCT in patients with MDS and AML, Annals of Hematology, 2014, 93, 7, 1097

    CrossRef

  4. 4
    Hala M. Farawela, Mervat M. Khorshied, Neemat M. Kassem, Heba A. Kassem, Hamdy M. Zawam, The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study, Journal of Cancer Research and Clinical Oncology, 2014, 140, 8, 1323

    CrossRef

  5. 5
    Mervat M. Khorshied, Wael A. Said, Hebat Allah M. Shaaban, Clinical implication of nucleophosmin gene mutation and Flt-3 internal tandem duplication in a cohort of Egyptian AML patients, Comparative Clinical Pathology, 2013, 22, 3, 497

    CrossRef

  6. 6
    Dario Campana, Wing Leung, Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation, British Journal of Haematology, 2013, 162, 2
  7. 7
    Elaine Coustan-Smith, Dario Campana, Should evaluation for minimal residual disease be routine in acute myeloid leukemia?, Current Opinion in Hematology, 2013, 20, 2, 86

    CrossRef

  8. 8
    Safaa M. El Karaksy, Nancy M. El Guindy, Heba M. Gouda, Mervat M. Khorshied, Iman A. Shaheen, Reham E. Abu Khalil, Noha Y. Ibrahim, Clinical relevance of angiopoietin-1, angiopoietin-2, and their receptor Tie-2 expression in acute myeloid leukemia, Comparative Clinical Pathology, 2012, 21, 6, 1171

    CrossRef

  9. 9
    Hans Minderman, Kristen Humphrey, Jane K. Arcadi, Andrzej Wierzbicki, Orla Maguire, Eunice S. Wang, AnneMarie W. Block, Sheila N. J. Sait, Thaddeus C. George, Paul K. Wallace, Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension, Cytometry Part A, 2012, 81A, 9
  10. 10
    Min Fang, Barry Storer, Brent Wood, Boglarka Gyurkocza, Brenda M. Sandmaier, Frederick R. Appelbaum, Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation, Cancer, 2012, 118, 9
  11. 11
    Håkon Reikvam, Kimberley Joanne Hatfield, Astrid Olsnes Kittang, Randi Hovland, Øystein Bruserud, Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  12. 12
    Safaa M. El Karaksy, Nancy M. El Guindy, Heba M. Gouda, Mervat M. Khorshied, Iman A. Shaheen, Reham E. Abu Khalil, Noha Y. Ibrahim, Clinical relevance of angiopoietin-1, angiopoietin-2, and their receptor Tie-2 expression in acute myeloid leukemia, Comparative Clinical Pathology, 2011, 20, 4, 341

    CrossRef

  13. 13
    T Lange, M Hubmann, R Burkhardt, G-N Franke, M Cross, M Scholz, S Leiblein, H K Al-Ali, J Edelmann, J Thiery, D Niederwieser, Monitoring of WT1 expression in PB and CD34+ donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning, Leukemia, 2011, 25, 3, 498

    CrossRef

  14. 14
    Nicolaus Kröger, Ulrike Bacher, Peter Bader, Sebastian Böttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, Homer Macapintac, Eduardo Olavarria, Jerald Radich, Wendy Stock, Julie M. Vose, Daniel Weisdorf, Andre Willasch, Sergio Giralt, Michael R. Bishop, Alan S. Wayne, NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, Acute Leukemias, and Myelodysplastic Syndromes, Biology of Blood and Marrow Transplantation, 2010, 16, 9, 1187

    CrossRef

  15. 15
    Kebede Hussein, Balkrishna Jahagirdar, Pankaj Gupta, Linda Burns, Karen Larsen, Daniel Weisdorf, Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia, American Journal of Hematology, 2008, 83, 6
  16. 16
    U. Bacher, C. Haferlach, FISH in der Diagnostik hämatologischer Neoplasien, medizinische genetik, 2008, 20, 4, 367

    CrossRef

  17. 17
    U Bacher, A R Zander, T Haferlach, S Schnittger, B Fehse, N Kröger, Minimal residual disease diagnostics in myeloid malignancies in the post transplant period, Bone Marrow Transplantation, 2008, 42, 3, 145

    CrossRef

  18. 18
    Torsten Haferlach, Ulrike Bacher, Wolfgang Kern, Susanne Schnittger, Winfried Gassmann, Claudia Haferlach, A comprehensive approach to the diagnosis of MDS after triage by morphology towards cytogenetics and other techniques, Cancer Treatment Reviews, 2007, 33, S31

    CrossRef

  19. 19
    Torsten Haferlach, Ulrike Bacher, Wolfgang Kern, Susanne Schnittger, Claudia Haferlach, Diagnostic pathways in acute leukemias: a proposal for a multimodal approach, Annals of Hematology, 2007, 86, 5, 311

    CrossRef

  20. 20
    Brent L. Wood, Myeloid Malignancies: Myelodysplastic Syndromes, Myeloproliferative Disorders, and Acute Myeloid Leukemia, Clinics in Laboratory Medicine, 2007, 27, 3, 551

    CrossRef

  21. 21
    Current Awareness in Hematological Oncology, Hematological Oncology, 2006, 24, 3
  22. 22
    Nick Goulden, Paul Virgo, David Grimwade, Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now, British Journal of Haematology, 2006, 134, 3